View source for D-lactic acidosis

==Background==
*D-lactic acidosis (D-lactate encephalopathy) is a rare cause of anion gap metabolic acidosis with neurologic symptoms that occurs primarily in patients with short bowel syndrome (SBS) and an intact colon<ref name="kowlgi">Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. ''Gastroenterol Res Pract''. 2015;2015:476215. PMID 25977687.</ref>
*Pathophysiology:
**Humans produce almost exclusively L-lactate; D-lactate is the mirror-image (enantiomer) produced by bacterial metabolism
**In SBS, unabsorbed carbohydrates reach the colon where they are fermented by colonic bacteria (''Lactobacillus'', ''Streptococcus bovis'', and other acid-resistant organisms) into organic acids including D-lactic acid
**The resulting acidic colonic environment further favors overgrowth of D-lactate-producing organisms → vicious cycle of escalating D-lactate production<ref name="kowlgi"/>
**Humans metabolize D-lactate much more slowly than L-lactate (via D-2-hydroxy acid dehydrogenase), so D-lactate accumulates in the blood
**D-lactate crosses the blood-brain barrier and causes neurologic dysfunction<ref name="petersen">Petersen C. D-lactic acidosis. ''Nutr Clin Pract''. 2005;20(6):634-645. PMID 16306300.</ref>
*Conditions associated with D-lactic acidosis:
**Short bowel syndrome (most common) — from surgical resection (Crohn's disease, mesenteric ischemia, volvulus, NEC, trauma), congenital abnormalities, or historical jejunoileal bypass for obesity<ref name="kowlgi"/>
**Small intestinal bacterial overgrowth (SIBO)
**Rarely: diabetes mellitus with intestinal dysmotility, chronic antibiotic use altering gut flora
*Episodes are typically precipitated by high carbohydrate meals (provides substrate for bacterial fermentation)<ref name="uribarri">Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. ''Medicine (Baltimore)''. 1998;77(2):73-82. PMID 9556700.</ref>
*The key diagnostic challenge: Standard laboratory L-lactate assays '''do NOT detect D-lactate''' — a normal reported "lactic acid" does not exclude D-lactic acidosis<ref name="bustos">Bustos D, Pernas JC, Perez-Ayuso E, et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. ''J Pediatr Surg''. 2004;39(2):e5. PMID 15065046.</ref>

==Clinical Features==
*Presentation is characterized by recurrent episodic encephalopathy and metabolic acidosis — typically following carbohydrate-rich meals
*Neurologic symptoms predominate (present in virtually all reported cases):<ref name="kowlgi"/>
**Altered mental status (confusion, disorientation, lethargy → stupor → coma)
**Slurred speech
**Ataxia and gait disturbance (often described as appearing "intoxicated")
**Impaired motor coordination
**Nystagmus
**Irritability, hostile/aggressive/bizarre behavior
**Weakness
**Headache
*GI symptoms:
**Nausea, vomiting
**Abdominal pain/distension (often chronic from underlying SBS)
**Diarrhea
*Classic pattern: Symptoms develop hours after a high-carbohydrate meal in a patient with known SBS, and resolve with fasting and correction of acidosis
*Neurologic symptoms may occur without significant acidosis in some cases, suggesting direct neurotoxicity of D-lactate beyond its contribution to acidosis<ref name="kowlgi"/>
*Episodes are recurrent — patients often present repeatedly before the diagnosis is made

==Differential Diagnosis==
*Other causes of anion gap metabolic acidosis (see [[Anion Gap Acidosis]]):
**[[Lactic Acidosis]] (L-lactic acid — sepsis, shock, mesenteric ischemia, seizures)
**[[Diabetic Ketoacidosis]]
**[[Toxic Alcohols]] (methanol, ethylene glycol)
**[[Salicylate Toxicity]]
**Uremia
*Other causes of encephalopathy in SBS patients:
**Thiamine deficiency ([[Wernicke encephalopathy]])
**[[Hepatic Encephalopathy]] (especially if intestinal failure–associated liver disease)
**[[Hypoglycemia]]
**Electrolyte derangements (hyponatremia, hyperammonemia)
**Medication toxicity
**[[Sepsis]] / bacteremia (SBS patients are at risk for catheter-related bloodstream infections)
**[[Mesenteric Ischemia]] (recurrent in SBS)
*Intoxication: Presentation mimics alcohol intoxication — patients may be dismissed as inebriated; serum ethanol level will be negative
*[[Ethanol Toxicity|Alcoholic ketoacidosis]]

==Evaluation==
===Workup===
*BMP/CMP: Anion gap metabolic acidosis (elevated anion gap); electrolytes, bicarbonate, BUN/creatinine, glucose
*ABG/VBG: Confirm metabolic acidosis; calculate anion gap
*Standard L-lactate level: May be normal or mildly elevated — a normal L-lactate in the setting of unexplained AGMA in a SBS patient should raise suspicion for D-lactic acidosis<ref name="kowlgi"/>
*D-lactate level: This is the confirmatory test
**Normal: < 0.25 mmol/L
**Diagnostic: > 3 mmol/L<ref name="bustos"/>
**This is a send-out test — NOT available on routine chemistry panels or point-of-care testing; results may take days
**Diagnosis must often be made clinically before results return
*Serum ketones: To exclude DKA and alcoholic ketoacidosis
*Serum ethanol, acetaminophen, salicylate levels: Exclude co-ingestants and toxic alcohols
*Serum osmolality and osmolar gap: Exclude toxic alcohol ingestion
*CBC: Leukocytosis may suggest alternative diagnosis (sepsis, ischemia)
*LFTs, ammonia: Exclude hepatic encephalopathy
*Thiamine level: Consider in malnourished SBS patients (Wernicke can coexist)
*Blood cultures: If febrile or concern for line sepsis
*CT abdomen: Consider to exclude bowel obstruction, bowel dilatation, or ischemia as alternative/contributing diagnoses

===Diagnosis===
*Diagnosis is primarily clinical — suspect D-lactic acidosis when:
**Anion gap metabolic acidosis PLUS encephalopathy/neurologic symptoms PLUS history of SBS or intestinal malabsorption PLUS normal or mildly elevated L-lactate
*The "lactate gap" — unexplained anion gap metabolic acidosis with normal L-lactate — is the hallmark laboratory clue<ref name="petersen"/>
*Confirmed by serum D-lactate > 3 mmol/L, but treatment should not be delayed pending this result
*Other organic acids (D-2-hydroxyisovaleric acid, D-2-hydroxyisocaproic acid) may contribute to the anion gap but are not routinely measured

==Management==
===Acute Treatment===
*NPO / fasting: Eliminates carbohydrate substrate for bacterial D-lactate production — this is the single most important acute intervention<ref name="kowlgi"/>
**IV fluids for hydration during fasting period
**Typically 24 hours of fasting followed by slow reintroduction of a low-carbohydrate diet
*IV sodium bicarbonate: For significant metabolic acidosis (pH < 7.2 or hemodynamically significant); correct acidosis gradually
*IV thiamine: 100 mg IV — administer empirically in all malnourished SBS patients (thiamine deficiency may coexist and mimics/worsens encephalopathy; thiamine is also a cofactor in D-lactate metabolism)<ref name="petersen"/>
*Enteral antibiotics: Target D-lactate-producing colonic flora<ref name="kowlgi"/>
**Metronidazole (oral)
**Oral vancomycin
**Oral neomycin or kanamycin
**Choice is often empiric; rotation may be needed for recurrent episodes
*Correct electrolyte abnormalities
*Avoid Lactated Ringer's solution — while LR contains only L-lactate and should not worsen D-lactic acidosis, normal saline is preferred to avoid any confusion

===Prevention of Recurrence===
*Low-carbohydrate diet: Reduce simple sugars and refined carbohydrates to limit substrate for bacterial fermentation — cornerstone of long-term management<ref name="uribarri"/>
*Probiotics: Non-D-lactate-producing strains (e.g. ''Lactobacillus rhamnosus GG'', ''Saccharomyces boulardii'') to recolonize with favorable flora — evidence is limited but promising<ref name="bustos"/>
*Intermittent or cycling enteral antibiotics: Reduce bacterial overgrowth
*Optimize SBS management: GI/nutrition consultation for intestinal rehabilitation, dietary counseling, parenteral nutrition adjustment
*Surgical options (refractory cases): Intestinal lengthening procedures, small bowel transplant, or colectomy (eliminates the site of D-lactate production — last resort)<ref name="kowlgi"/>

==Disposition==
*Admit:
**All patients with suspected or confirmed D-lactic acidosis
**Significant metabolic acidosis requiring IV bicarbonate
**Altered mental status (monitor for airway compromise)
**Inability to tolerate oral intake
**Need for IV hydration and serial lab monitoring
*ICU admission:
**Severe encephalopathy (GCS significantly depressed, inability to protect airway)
**Hemodynamic instability
**Severe acidosis (pH < 7.1)
*Consultations:
**GI / nutrition: For long-term SBS management, dietary counseling, and prevention of recurrence
**Medical toxicology: If diagnostic uncertainty regarding anion gap etiology
**Surgery: If bowel obstruction, ischemia, or surgical SBS management is being considered
*Discharge:
**Once neurologic symptoms have fully resolved, acidosis has corrected, and patient tolerates oral low-carbohydrate diet
**Arrange close GI follow-up
**Provide dietary counseling: avoid high-sugar/high-carbohydrate meals
**Educate patient/family on recognition of recurrent episodes and need for early ED presentation
*Prognosis: With appropriate treatment, acute episodes typically resolve within 24–48 hours of fasting and supportive care; long-term prognosis depends on the underlying SBS and dietary adherence<ref name="kowlgi"/>

==See Also==
*[[Lactic Acidosis]]
*[[Anion gap acidosis]]
*[[Metabolic Acidosis]]
*[[Altered mental status]]
*[[Wernicke encephalopathy]]
*[[Short bowel syndrome]]
*[[Acid-Base Disorders]]

==External Links==
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC4421027/ D-lactic acidosis: an underrecognized complication of short bowel syndrome - Gastroenterol Res Pract 2015]
*[https://pubmed.ncbi.nlm.nih.gov/9556700/ D-lactic acidosis: review of clinical presentation, biochemical features, and pathophysiologic mechanisms - Medicine 1998]
*[https://pubmed.ncbi.nlm.nih.gov/16306300/ D-lactic acidosis - Nutr Clin Pract 2005]
*[https://pubmed.ncbi.nlm.nih.gov/15065046/ D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics - J Pediatr Surg 2004]
*[https://www.mayoclinicproceedings.org/article/S0025-6196(11)63729-4/fulltext D-lactic acidosis: pathologic consequence of saprophytism - Mayo Clin Proc 1998]

==References==
<references/>

[[Category:FEN]] [[Category:GI]] [[Category:Heme/Onc]]